Literature DB >> 17644204

Viral gene expression and provirus load of Orf-A defective FIV in lymphoid tissues and lymphocyte subpopulations of neonatal cats during acute and chronic infections.

Janelle M Novak1, P Cynthia Crawford, Holly M Kolenda-Roberts, Calvin M Johnson, Ayalew Mergia.   

Abstract

Neonatal cats were infected with a wild type (JSY3) or orf-A defective (JSY3DeltaORF-A) feline immunodeficiency virus (FIV) to determine the provirus load and level of viral gene expression at the acute versus chronic stages of infection. FIV DNA in the thymus, lymph node, peripheral blood mononuclear cells (PBMCs) and lymphocyte subpopulations at week 8 post-infection was lower in animals infected with JSY3DeltaORF-A as compared to that of JSY3. At week 16 we observed no significant difference in provirus load between the two groups except for B cells where it was higher in the JSY3 infection. In B cells proviral burden was found to be the same in animals infected with JSY3 for both time points. In the chronic stage, therefore, proviral burden dominates in B cells for JSY3, whereas the level of JSY3DeltaORF-A was lower with comparable values for all lymphocytes at both weeks 8 and 16. Gene expression profiles as measured by real time PCR for gag and rev transcripts revealed decreased levels of JSY3DeltaORF-A mRNAs as compared to that of JSY3. The JSY3 chronic phase infection showed viral gene expression to be higher in B cells relative to CD4+ and CD8+ cells. The presence of viral RNA in CD8 and B cells during the chronic infection implicates active virus replication. Hematological profiles revealed that there was a decline in the number of B cells in JSY3DeltaORF-A-infected cats during the chronic stage of infection while no significant change was observed in animals infected with the wild type virus. Comparative analysis of cell numbers to provirus load and levels of viral transcripts in CD4+ and CD8+, however, did not correlate cell numbers to the levels of viral DNA and gene expression. It remains to be determined whether the relatively high virus burden in B cells as compared to CD4+ and CD8+ cells reflects a role for Orf-A in a shift to B cell virus load during the chronic stage of FIV infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17644204      PMCID: PMC2211428          DOI: 10.1016/j.virusres.2007.06.001

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  39 in total

Review 1.  FIV infection of the domestic cat: an animal model for AIDS.

Authors:  B J Willett; J N Flynn; M J Hosie
Journal:  Immunol Today       Date:  1997-04

Review 2.  Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease.

Authors:  E A Berger; P M Murphy; J M Farber
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

3.  CD8+ thymic lymphocytes express reduced levels of CD8beta and increased interferon gamma in cats perinatally infected with the JSY3 molecular clone of feline immunodeficiency virus.

Authors:  M S Orandle; P C Crawford; J K Levy; R Udoji; G P Papadi; T Ciccarone; A Mergia; C M Johnson
Journal:  AIDS Res Hum Retroviruses       Date:  2000-10-10       Impact factor: 2.205

4.  Thymic lesions in cats infected with a pathogenic molecular clone or an ORF-A/2-deficient molecular clone of feline immunodeficiency virus.

Authors:  R M Norway; P C Crawford; C M Johnson; A Mergia
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

5.  Tissue dynamics of CD8 lymphocytes that suppress viral replication in cats infected neonatally with feline immunodeficiency virus.

Authors:  P C Crawford; G P Papadi; J K Levy; N A Benson; A Mergia; C M Johnson
Journal:  J Infect Dis       Date:  2001-08-24       Impact factor: 5.226

6.  Differential cell tropism of feline immunodeficiency virus molecular clones in vivo.

Authors:  G A Dean; S Himathongkham; E E Sparger
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

7.  Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses.

Authors:  B J Willett; L Picard; M J Hosie; J D Turner; K Adema; P R Clapham
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

8.  Demonstration that orf2 encodes the feline immunodeficiency virus transactivating (Tat) protein and characterization of a unique gene product with partial rev activity.

Authors:  A de Parseval; J H Elder
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

9.  Feline immunodeficiency virus ORF-Ais required for virus particle formation and virus infectivity.

Authors:  Malou C Gemeniano; Earl T Sawai; Christian M Leutenegger; Ellen E Sparger
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

10.  Development of feline immunodeficiency virus ORF-A (tat) mutants: in vitro and in vivo characterization.

Authors:  M Pistello; M Moscardini; P Mazzetti; F Bonci; L Zaccaro; P Isola; G Freer; S Specter; D Matteucci; M Bendinelli
Journal:  Virology       Date:  2002-06-20       Impact factor: 3.616

View more
  1 in total

1.  Dual-emission fluorescence resonance energy transfer (FRET) real-time PCR differentiates feline immunodeficiency virus subtypes and discriminates infected from vaccinated cats.

Authors:  Chengming Wang; Calvin M Johnson; Sudhir K Ahluwalia; Erfan Chowdhury; Yihang Li; Dongya Gao; Anil Poudel; K Shamsur Rahman; Bernhard Kaltenboeck
Journal:  J Clin Microbiol       Date:  2010-03-24       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.